This week, use of systemic corticosteroids is linked with worse covid-19 outcomes; an investigational antiviral drug reduces risk for hospitalization and death by about 50% in patients with COVID-19; Pfizer-BioNTech submit vaccine data for children aged 5 to 11 to FDA; and more.

Read the full coverage here:

Use of systemic corticosteroids linked with worse COVID-19 outcomes

Antiviral reduces risk for hospitalization, death by about 50% in patients with COVID-19

Pfizer-BioNTech submit vaccine data for children aged 5 to 11 to FDA

Unlike flu, cold viruses persisted during pandemic, study finds

AstraZeneca COVID-19 vaccine 74% effective, protects against asymptomatic disease

References:

Yochai A, et al. Asthma treatment: clinical and translational science. Presented at: European Respiratory Society International Congress; Sept. 5-8, 2021 (virtual meeting).

Press Release

Press Release

Rankin, DA, et al. Abstract 154. Presented at: IDWeek; Sept. 29-Oct. 3, 2021 (virtual meeting).

Sobieszczyk M, et al. Abstract LB6. Presented at: IDWeek; Sept. 29-Oct. 3, 2021 (virtual meeting).